BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17117159)

  • 1. Commonly used caspase inhibitors designed based on substrate specificity profiles lack selectivity.
    Berger AB; Sexton KB; Bogyo M
    Cell Res; 2006 Dec; 16(12):961-3. PubMed ID: 17117159
    [No Abstract]   [Full Text] [Related]  

  • 2. Some commonly used caspase substrates and inhibitors lack the specificity required to monitor individual caspase activity.
    Pereira NA; Song Z
    Biochem Biophys Res Commun; 2008 Dec; 377(3):873-7. PubMed ID: 18976637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways.
    McStay GP; Salvesen GS; Green DR
    Cell Death Differ; 2008 Feb; 15(2):322-31. PubMed ID: 17975551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Click" synthesis of small-molecule inhibitors targeting caspases.
    Ng SL; Yang PY; Chen KY; Srinivasan R; Yao SQ
    Org Biomol Chem; 2008 Mar; 6(5):844-7. PubMed ID: 18292873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of photochemically controllable caspase-3.
    Endo M; Nakayama K; Kaida Y; Majima T
    Angew Chem Int Ed Engl; 2004 Oct; 43(42):5643-5. PubMed ID: 15495205
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular Formal Concept Analysis for compound selectivity profiling in biologically annotated databases.
    Lounkine E; Stumpfe D; Bajorath J
    J Chem Inf Model; 2009 Jun; 49(6):1359-68. PubMed ID: 19537827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A RSK kinase inhibitor reporting its selectivity in vivo.
    Frödin M
    Nat Chem Biol; 2007 Mar; 3(3):138-9. PubMed ID: 17301799
    [No Abstract]   [Full Text] [Related]  

  • 8. Caspases: structure-guided design of drugs to control cell death.
    Weber IT; Fang B; Agniswamy J
    Mini Rev Med Chem; 2008 Oct; 8(11):1154-62. PubMed ID: 18855730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The apoptotic effects of oxidative stress and antiapoptotic effects of caspase inhibitors on rat notochordal cells.
    Kim KW; Ha KY; Lee JS; Rhyu KW; An HS; Woo YK
    Spine (Phila Pa 1976); 2007 Oct; 32(22):2443-8. PubMed ID: 18090083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Chemical Society--230th National Meeting. Technical achievements in organic chemistry.
    Rotella DP
    IDrugs; 2005 Nov; 8(11):876-7. PubMed ID: 16254773
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyrimidine-based inhibitors of CaMKIIdelta.
    Mavunkel B; Xu YJ; Goyal B; Lim D; Lu Q; Chen Z; Wang DX; Higaki J; Chakraborty I; Liclican A; Sideris S; Laney M; Delling U; Catalano R; Higgins LS; Wang H; Wang J; Feng Y; Dugar S; Levy DE
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2404-8. PubMed ID: 18334293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase assays: identifying caspase activity and substrates in vitro and in vivo.
    Pop C; Salvesen GS; Scott FL
    Methods Enzymol; 2008; 446():351-67. PubMed ID: 18603133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turning promiscuous kinase inhibitors into safer drugs.
    Zhang X; Crespo A; Fernández A
    Trends Biotechnol; 2008 Jun; 26(6):295-301. PubMed ID: 18403035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase substrates.
    Timmer JC; Salvesen GS
    Cell Death Differ; 2007 Jan; 14(1):66-72. PubMed ID: 17082814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redesigning kinase inhibitors to enhance specificity.
    Crespo A; Zhang X; Fernández A
    J Med Chem; 2008 Aug; 51(16):4890-8. PubMed ID: 18680272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of recombinant caspase specificity by competitive substrates.
    Benkova B; Lozanov V; Ivanov IP; Mitev V
    Anal Biochem; 2009 Nov; 394(1):68-74. PubMed ID: 19595985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspases: determination of their activities in apoptotic cells.
    Vaculova A; Zhivotovsky B
    Methods Enzymol; 2008; 442():157-81. PubMed ID: 18662569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].
    Jia H; Guo YS; Ge YY; Wen H; Yang J; Yang XY; Du GH; Yang GZ
    Yao Xue Xue Bao; 2007 Dec; 42(12):1271-81. PubMed ID: 18338640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of aza-peptide electrophile activity-based probes of caspases.
    Sexton KB; Kato D; Berger AB; Fonovic M; Verhelst SH; Bogyo M
    Cell Death Differ; 2007 Apr; 14(4):727-32. PubMed ID: 17170749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-guided design of AMP mimics that inhibit fructose-1,6-bisphosphatase with high affinity and specificity.
    Erion MD; Dang Q; Reddy MR; Kasibhatla SR; Huang J; Lipscomb WN; van Poelje PD
    J Am Chem Soc; 2007 Dec; 129(50):15480-90. PubMed ID: 18041833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.